Patent intelligence · EP
EP 1148873
HOCHREINES ETHYLEICOSAPENTAENAT UND ANDERE EPA-DERIVATE ZUR BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN
HOCHREINES ETHYLEICOSAPENTAENAT UND ANDERE EPA-DERIVATE ZUR BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN
Patent details — EP 1148873
- Jurisdiction
- EP
- Status
- expired
- Grant date
- Oct 31, 2001
- Expiration
- Oct 26, 2021
- Applicant
- LAXDALE LTD [GB]
- CPC classes
- A61K 31/ 00 A I, A61K 31/ 20 A I, A61K 31/ 38 A I, A61K 31/ 40 A I
Quick answer
EP 1148873 (HOCHREINES ETHYLEICOSAPENTAENAT UND ANDERE EPA-DERIVATE ZUR BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN) is held by LAXDALE LTD [GB]. Status: expired. Granted Oct 31, 2001. Expires Oct 26, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- LAXDALE LTD [GB]
- Grant date
- Expiration
- Claims
- —
- CPC classes
- A61K 31/ 00 A I, A61K 31/ 20 A I, A61K 31/ 38 A I, A61K 31/ 40 A I, A61K 31/ 54 A I, A61K 31/ 55 A I
More from LAXDALE LTD [GB]
Related pharmaceutical patents in our USPTO index.
-
CA 2754902
COMPOSES D'ACIDE GRAS ESSENTIEL
granted -
IL 159038
USE OF COENZYME Q AND EICOSAPENTAENOIC ACID (EPA) FOR THE PREPARATION OF MEDICAMENTS
granted -
DK 1007053
Behandling af smerte
granted -
CA 2591889
TRAITEMENT DE LA DEPRESSION MELANCOLIQUE SEVERE A L'AIDE D'EPA
granted -
IS 7744
Eikósapentanó sýra (EPA) til notkunar við meðhöndlun á lystarstoli (AN) og matgræðgi
expired -
CA 2506727
TRAITEMENT DE LA MALADIE DE HUNTINGTON AU MOYEN D'ACIDE EICOSAPENTAENOIQUE
expired -
EP 1392276
VERSTÄRKTE WIRKUNG MEHRFACH UNGESÄTTIGTER FETTSÄUREN
expired
Frequently asked questions
What is US patent 1148873?
EP 1148873 (HOCHREINES ETHYLEICOSAPENTAENAT UND ANDERE EPA-DERIVATE ZUR BEHANDLUNG VON NEUROLOGISCHEN ERKRANKUNGEN) is held by LAXDALE LTD [GB]. Status: expired. Granted Oct 31, 2001. Expires Oct 26, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.
Who owns EP 1148873?
LAXDALE LTD [GB] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 11 pharmaceutical patents for this assignee.
When does EP 1148873 expire?
Our index shows an expiration date of Oct 26, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.